Redox Pharmachem Profile
Key Indicators
- Authorised Capital ₹ 5.00 M
as on 03-01-2025
- Paid Up Capital ₹ 5.00 M
as on 03-01-2025
- Company Age 20 Year, 1 Month
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 1.89 Cr
as on 03-01-2025
- Revenue -4.29%
(FY 2022)
- Profit -191.44%
(FY 2022)
- Ebitda -107.23%
(FY 2022)
- Net Worth -4.47%
(FY 2022)
- Total Assets -4.36%
(FY 2022)
About Redox Pharmachem
The Company is engaged in the Chemicals And Materials Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 5.00 M and a paid-up capital of Rs 5.00 M.
The company has closed loans amounting to ₹1.89 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Suresh Jaipuria and Uttam Jaipuria serve as directors at the Company.
- CIN/LLPIN
U24231DL2004PTC130700
- Company No.
130700
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
22 Nov 2004
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
Delhi, India
- Telephone
- Email Address
- Website
- Social Media-
What products or services does Redox Pharmachem Private Limited offer?
Redox Pharmachem Private Limited offers a wide range of products and services, including Bird Food, Poultry & Animal Food, Animal Feed Supplement, Feed Additives, Veterinary Medicines, Veterinary Drugs, Poultry Feed Additives, Vitamin E Selenium Supplement, Poultry Feed Supplements.
Who are the key members and board of directors at Redox Pharmachem?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Uttam Jaipuria  | Director | 22-Nov-2004 | Current |
| Suresh Jaipuria | Director | 22-Nov-2004 | Current |
Financial Performance of Redox Pharmachem.
Redox Pharmachem Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 4.29% decrease. The company also saw a substantial fall in profitability, with a 191.44% decrease in profit. The company's net worth dipped by a decrease of 4.47%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Redox Pharmachem?
In 2022, Redox Pharmachem had a promoter holding of 93.00% and a public holding of 7.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Cryogenics India LimtedActive 50 years 11 monthsSuresh Jaipuria and Uttam Jaipuria are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Others Creation Date: 10 Nov 2021 | ₹0.50 M | Satisfied |
Punjab National Bank Creation Date: 31 Jul 2009 | ₹0.50 M | Satisfied |
Punjab National Bank Creation Date: 29 Dec 2007 | ₹2.50 M | Satisfied |
How Many Employees Work at Redox Pharmachem?
Redox Pharmachem has a workforce of 10 employees as of Mar 30, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Redox Pharmachem, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Redox Pharmachem's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
